Back

Y-mAbs Therapeutics Stock Predictions

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm

Buy

YMAB
Y-mAbs Therapeutics

Last Price:

14.00

Seasonality Move:

-10.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market

Y-mAbs Therapeutics Stock Forecast

Over the next 52 weeks, Y-mAbs Therapeutics has on average historically risen by 9.7% based on the past 5 years of stock performance.
Y-mAbs Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Is Y-mAbs Therapeutics Stock Undervalued?
The current Y-mAbs Therapeutics [YMAB] share price is $13.57. The Score for YMAB is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
YMAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Y-mAbs Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Y-mAbs Therapeutics has on average historically risen by 9.7% based on the past 5 years of stock performance.

Y-mAbs Therapeutics Stock Rating

Buy

Y-mAbs Therapeutics (YMAB) is a Buy

Is Y-mAbs Therapeutics overpriced?

Y-mAbs Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Y-mAbs Therapeutics Stock Price History

Is YMAB stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and YMAB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

ymabs.com

52-Week Data

52-Week High:

20.90

52-Week Low:

4.69

Prediction Charts

Market Cap:

604.81M

Price in USD:

13.57

Volume:

321.09K

Beta:

0.79

Technical Analysis

SMA50:

12.75

SMA100:

12.75

SMA200:

12.56

52-Wk Change:

167.65%

Stock Predictions

Is Y-mAbs Therapeutics stock public?
Yes, Y-mAbs Therapeutics is a publicly traded company.
What is the Y-mAbs Therapeutics stock quote today?
The Y-mAbs Therapeutics stock price is 13.57 USD today.
How to buy Y-mAbs Therapeutics stock online?
You can buy Y-mAbs Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Aug-29	15.49	14.02	15.61	14.02
Aug-30	14.07	14.33	14.33	13.61
Sep-3	14.08	13.89	14.82	13.42
Sep-4	13.88	14.36	14.50	13.43
Sep-5	14.40	14.01	14.48	13.66
Sep-6	14.04	13.82	14.42	13.27
Sep-9	13.89	13.38	14.42	13.20
Sep-10	13.38	13.40	13.43	12.90
Sep-11	13.28	13.27	13.81	13.17
Sep-12	13.26	13.23	13.62	12.95
Sep-13	13.43	13.74	13.78	13.23
Sep-16	13.74	13.01	13.85	12.78
Sep-17	13.18	14.31	14.47	12.95
Sep-18	14.25	13.57	14.42	13.50

Y-mAbs Therapeutics Earnings

Y-mAbs Therapeutics Earnings Report: Per Share Y-mAbs Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Y-mAbs Therapeutics Forecast Revenue Growth

Y-mAbs Therapeutics Stock Analysis: Historical quarterly revenues per share for Y-mAbs Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.07 per share, and an increase next year of $0.09 per share.

* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.